America Great Health (AAGH) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1609 W VALLEY BLVD UNIT 338A ALHAMBRA, CA 91803 |
| State of Incorp. | CA |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 MRQ | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 55 | 54 | 63 | 396 | 0 | 0 | |||
| Cash and cash equivalent | 55 | 54 | 63 | 396 | 0 | 0 | |||
| Receivables | 55 | 1 | 61 | 3 | |||||
| Inventory, net of allowances, customer advances and progress billings | 83 | 108 | 116 | 8 | 1 | ||||
| Inventory | 83 | 108 | 116 | 8 | 1 | ||||
| Prepaid expense | 12 | ||||||||
| Advances on inventory purchases | 17 | 17 | 18 | ||||||
| Other undisclosed current assets | 20 | 1 | |||||||
| Total current assets: | 225 | 179 | 197 | 483 | 4 | 0 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 43 | 42 | 94 | 127 | ✕ | ||||
| Property, plant and equipment | 43 | 58 | 24 | 13 | |||||
| Other noncurrent assets | 8 | 14 | |||||||
| Other undisclosed noncurrent assets | 12 | 12 | 8 | ||||||
| Total noncurrent assets: | 98 | 120 | 140 | 140 | |||||
| TOTAL ASSETS: | 323 | 299 | 336 | 623 | 4 | 0 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,436 | 1,451 | 1,438 | 57 | 49 | 39 | |||
| Taxes payable | ✕ | ✕ | ✕ | 1 | 2 | 1 | |||
| Accounts payable | 242 | 334 | |||||||
| Accrued liabilities | 2 | 4 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 1,434 | 1,205 | 1,103 | 56 | 48 | 38 | |||
| Deferred revenue | 60 | 223 | 157 | ✕ | |||||
| Debt | 607 | 705 | 184 | ||||||
| Other liabilities | 1,110 | 425 | |||||||
| Due to related parties | ✕ | ✕ | 574 | 324 | 168 | 128 | |||
| Other undisclosed current liabilities | 381 | 288 | 405 | 51 | 2 | 1 | |||
| Total current liabilities: | 3,593 | 3,092 | 2,757 | 432 | 219 | 168 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,834 | 1,123 | 1,055 | 658 | |||||
| Long-term debt, excluding current maturities | 1,834 | 1,123 | 1,032 | 582 | |||||
| Liabilities, other than long-term debt | 22 | ||||||||
| Operating lease, liability | 22 | 23 | 76 | ✕ | |||||
| Other undisclosed noncurrent liabilities | 186 | 610 | 361 | (76) | |||||
| Total noncurrent liabilities: | 2,042 | 1,733 | 1,439 | 658 | |||||
| Total liabilities: | 5,635 | 4,825 | 4,197 | 1,091 | 219 | 168 | |||
| Equity | |||||||||
| Equity, attributable to parent | (5,231) | (4,451) | (3,802) | (468) | (215) | (168) | |||
| Additional paid in capital | 5,019 | 4,732 | 4,620 | 3,088 | 3,072 | 3,067 | |||
| Accumulated other comprehensive income (loss) | (1) | (1) | 0 | ||||||
| Accumulated deficit | (10,249) | (9,183) | (8,422) | (3,556) | (3,287) | (3,235) | |||
| Equity, attributable to noncontrolling interest | (80) | (75) | (59) | ||||||
| Total equity: | (5,312) | (4,526) | (3,860) | (468) | (215) | (168) | |||
| TOTAL LIABILITIES AND EQUITY: | 323 | 299 | 336 | 623 | 4 | 0 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 295 | 204 | 105 | 196 | 5 | |||
| Other income | 35 | 0 | ||||||
| Cost of revenue (Cost of Product and Service Sold) | (125) | (36) | (1,588) | (144) | (3) | |||
| Gross profit: | 170 | 169 | (1,484) | 51 | 2 | |||
| Operating expenses | (952) | (661) | (3,250) | (295) | (48) | (47) | ||
| Operating loss: | (783) | (493) | (4,734) | (244) | (46) | (47) | ||
| Nonoperating expense | (444) | (285) | (191) | (25) | (5) | (17) | ||
| Interest and debt expense | (444) | (320) | (191) | (20) | (5) | (4) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 4 | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (1,670) | (1,097) | (5,116) | (289) | (56) | (64) | ||
| Loss from equity method investments | (1) | |||||||
| Other undisclosed income from continuing operations before income taxes | 444 | 320 | 191 | 20 | 5 | |||
| Loss from continuing operations before income taxes: | (1,226) | (777) | (4,925) | (269) | (51) | (65) | ||
| Income tax expense | (1) | (1) | ||||||
| Loss from continuing operations: | (1,226) | (777) | (4,925) | (269) | (52) | (66) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (4,925) | (269) | (52) | (66) | |
| Other undisclosed net income | 1 | |||||||
| Net loss: | (1,226) | (777) | (4,925) | (269) | (52) | (65) | ||
| Net income attributable to noncontrolling interest | 6 | 16 | 59 | |||||
| Other undisclosed net loss attributable to parent | (16) | (59) | ||||||
| Net loss attributable to parent: | (1,221) | (777) | (4,925) | (269) | (52) | (65) | ||
| Other undisclosed net income available to common stockholders, basic | 16 | 59 | ||||||
| Net loss available to common stockholders, diluted: | (1,221) | (761) | (4,866) | (269) | (52) | (65) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (1,226) | (777) | (4,925) | (269) | (52) | (65) | ||
| Comprehensive loss: | (1,226) | (777) | (4,925) | (269) | (52) | (65) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 6 | 16 | 59 | |||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 1 | 1 | (0) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (1,220) | (761) | (4,866) | (269) | (52) | (65) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.